Invesco
IMUC

Invesco’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Invesco’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,992
Closed -$2K – 3989
2018
Q3 		$2K Sell
10,992
-1,373
-11% -$316 ﹤0.01% 3885
2018
Q2 		$3K Buy
+12,365
New +$3.21K ﹤0.01% 3873

Other funds holding IMUC

WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Invesco's IMUC Position: Q4 2018 in Review

Invesco sold out of ImmunoCellular Therapeutics, Ltd. (IMUC) in Q4 2018, closing a stake of 10,992 shares — an estimated $2K sold.

Invesco first reported a position in IMUC in Q2 2018 and held it in 2 quarters. The position peaked at $3K in Q2 2018. 3 funds tracked by Wall St. Rank hold IMUC as of Q4 2018.

  • Invesco reported no remaining ImmunoCellular Therapeutics, Ltd. position as of Q4 2018 after selling out during the quarter.
  • Invesco sold 10,992 ImmunoCellular Therapeutics, Ltd. shares in Q4 2018, an estimated $2K.
  • Invesco first reported a position in ImmunoCellular Therapeutics, Ltd. in Q2 2018 and held it in 2 quarters.
  • Invesco's ImmunoCellular Therapeutics, Ltd. position peaked at $3K in Q2 2018.
  • 3 funds tracked by Wall St. Rank held ImmunoCellular Therapeutics, Ltd. as of Q4 2018.

Based on Invesco's 13F filing for Q4 2018, filed 14 Feb 2019.